Skip to main content

Table 5 Area under the receiver operating characteristic curve values for mortality prediction by biomarkers

From: Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study

 

7-day mortality

In-hospital mortality

Plasma NGAL

0.79 (0.67 to 0.88)

0.68 (0.53 to 0.80)

Plasma IL-6

0.82 (0.57 to 0.94)

0.66 (0.50 to 0.79)

Plasma EPO

0.63 (0.38 to 0.90)

0.60 (0.44 to 0.75)

Serum creatinine

0.67 (0.53 to 0.78)

0.61 (0.45 to 0.74)

Urinary TIMP-2

0.83 (0.59 to 0.94)*

0.74 (0.60 to 0.85)*

Urinary NAG

0.80 (0.58 to 0.92)*

0.70 (0.54 to 0.82)

  1. EPO, Erythropoietin; IL, Interleukin; NAG, N-acetyl-β-d-glucosaminidase; NGAL, Neutrophil gelatinase-associated lipocalin; TIMP-2, Tissue inhibitor of matrix metalloproteinase-2. *p < .05 vs. serum creatinine.